According to recent reports, AliveCor will no longer manufacture the Apple Watch ECG accessory known as the KardiaBand. The enterprise will proceed with the sale of further products.
The KardiaBand is an Apple Watch band that gives customers the ability to take EKG readings in as little as 30 seconds. When you want to take a reading, you press down on the band with your thumb. The information is then processed by the program that comes with the Apple Watch. You can also make voice recordings with the app, which you can then send to your doctor along with the EKG reading.
MobiHealthNews reports that AliveCor has decided to discontinue production of the product. According to the information available on the Amazon vendor page, the product was taken off the market in June.
According to the AliveCor website, the company was “honored” to launch the first accessory for the Apple Watch that was certified by the FDA in 2017.
Since then, we’ve been concentrating on increasing the capabilities of our KardiaMobile products, and we have recently unveiled the KardiaMobile 6L, which is the first six-lead mobile electrocardiogram of its kind. While we keep coming up with new technologies and ways to do things, our goal is to teach our clients how to improve their cardiovascular health so they can make better decisions.
It shouldn’t come as much of a shock that AliveCor has decided to stop supporting the product. Since the Apple Watch Series 4 already includes an electrocardiogram (ECG or EKG), it is reasonable to assume that all devices of the following generation will include this capability.
According to AliveCor’s statement, the company will maintain its support for the band’s current owners indefinitely. In addition to this, the privately owned medical and health care company with its headquarters in Mountain View, California, will keep selling similar products.
This includes the KardiaMobile 6L, which was just released recently (view on Amazon). This device has a 6-lead system and is able to detect around one hundred distinct ailments, in contrast to its prior product line and the Series 4 Watch, both of which have a single-lead ECG. ECG readers in a medical facility each contain 12 leads that are spread out across a patient’s chest in order to record their cardiac data. The more leads you have, the clearer your picture of your heart will be.
In a statement to MobiHealthNews, AliveCor stated, “Despite pivoting away from KardiaBand, we still very much feel that wearables have value in healthcare and will continue to seek ways to be innovative in this field.” KardiaBand was the company’s first product.
“We are excited to be investing in new categories of wearables and giving our customers additional possibilities to interact with the data they collect about their health,” said one of the company’s representatives.